Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
McCormick & Company Voting | MKC-V | Apr 19, 2024 | 73.25 | +0.62 |
McDonalds | MCD | Apr 19, 2024 | 271.99 | +0.37 |
McEwen Mining | MUX | Apr 19, 2024 | 11.22 | +1.63 |
McGrath RentCorp | MGRC | Apr 19, 2024 | 110.39 | -0.25 |
McKesson | MCK | Apr 19, 2024 | 524.83 | +1.16 |
MDB Capital Holdings | MDBH | Apr 19, 2024 | 8.55 | +0.23 |
MDJM | MDJH | Apr 19, 2024 | 1.04 | -11.11 |
MDU Resources Group | MDU | Apr 19, 2024 | 24.01 | +1.74 |
MDxHealth | MDXH | Apr 19, 2024 | 2.23 | -2.75 |
Medalist Diversified Reit | MDRR | Apr 19, 2024 | 5.68 | +3.84 |
Medalist Diversified REIT A Pref | MDRRP | Apr 19, 2024 | 24.51 | 0.00 |
Medallion Bank F Pref | MBNKP | Apr 19, 2024 | 24.86 | -0.40 |
Medallion Financial | MFIN | Apr 19, 2024 | 7.79 | -1.14 |
MediaAlpha | MAX | Apr 19, 2024 | 19.04 | +2.59 |
Mediaco A | MDIA | Apr 19, 2024 | 2.28 | -16.18 |
Medical Properties Trust | MPW | Apr 19, 2024 | 4.42 | -11.42 |
MediciNova | MNOV | Apr 19, 2024 | 1.39 | -0.71 |
Medifast | MED | Apr 19, 2024 | 32.44 | -0.09 |
Medigus ADR | MDGS | Apr 19, 2024 | 2.36 | 0.00 |
MEDIROM Healthcare Technologies ADR | MRM | Apr 19, 2024 | 6.08 | +1.33 |
MediWound | MDWD | Apr 19, 2024 | 15.77 | -7.18 |
Mednax | MD | Apr 19, 2024 | 9.03 | +2.50 |
Medpace | MEDP | Apr 19, 2024 | 372.00 | -0.62 |
Medtronic | MDT | Apr 19, 2024 | 79.48 | +0.37 |
Mega Matrix | MPU | Apr 19, 2024 | 2.43 | -0.82 |
Megacap 300 Growth Index ETF Vanguard | MGK | Apr 19, 2024 | 267.84 | -2.43 |
Megacap 300 Index ETF Vanguard | MGC | Apr 19, 2024 | 177.06 | -1.13 |
Megacap 300 Value Index ETF Vanguard | MGV | Apr 19, 2024 | 114.63 | +0.78 |
MEI Pharma | MEIP | Apr 19, 2024 | 3.25 | 0.00 |
Meihua International Medical Technologies | MHUA | Apr 19, 2024 | 0.64 | +1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.